Clik here to view.
Discovery Provides Blueprint for New Drugs That Can Inhibit Hepatitis C Virus
Finding Could Pave Way for Drugs Against Virus That Kills More In US Than HIV Chemists at the University of California, San Diego have produced the first high resolution structure of a molecule that...
View ArticleClik here to view.
Combined Health Agencies Honors Four UC San Diego Health Heroes
Brain stimulation surgery for patients with Parkinson’s disease; promoting liver health on a national level; leading one of the nation’s top ALS clinics; and designing a law that protects the rights of...
View ArticleClik here to view.
Modest Alcohol Use Lowers Risk and Severity of Some Liver Disease
People with nonalcoholic fatty liver disease (NALFD) who consume alcohol in modest amounts – no more than one or two servings per day – are half as likely to develop hepatitis as non-drinkers with the...
View ArticleClik here to view.
Scarring Cells Revert to Inactive State As Liver Heals
Research with mice reveals possible strategy to reverse fibrosis in liver and other organs An international team of scientists, led by researchers at the University of California, San Diego School of...
View ArticleClik here to view.
Blocking Tumor-Induced Inflammation Impacts Cancer Development
How tumors exploit microflora and immune cells to fuel growth Researchers at the University of California, San Diego School of Medicine report the discovery of microbial–dependent mechanisms through...
View ArticleClik here to view.
Two from UCSD School of Medicine Named Members of the Institute of Medicine
The Institute of Medicine (IOM) today announced the names of 70 new members and 10 foreign associates during its 42nd annual meeting. Included are two new members from the University of California,...
View ArticleClik here to view.
Dr. Rohit Loomba on Fatty Liver Disease: HHMI Bulletin
Dr. Rohit Loomba, a UCSD hepatologist who specializes in fatty liver disease, is interviewed in an article about the disease in the Fall 2012 health bulletin from the Howard Hughes Medical Institute....
View ArticleClik here to view.
Dr. David Brenner Speaking at Grand Rounds March 13
Speaking at Medicine Grand Rounds on March 13 is Dr. David A. Brenner, vice chancellor for health sciences, dean of the UCSD School of Medicine and professor of medicine in the Division of...
View ArticleClik here to view.
UC San Diego-Human Longevity Inc. Agreement Seeks to Accelerate Medical Science
Thousands of patient genomes expected to fuel diverse medical research, beginning with cancer The new collaborative research agreement between Human Longevity Inc. (HLI) and the University of...
View ArticleClik here to view.
UC San Diego Health System Retains #1 Ranking
US News & World Report Cites Region’s Only Academic Health System Among Nation’s Best UC San Diego Health System remains among the nation’s best, according to the U.S. News & World Report’s...
View ArticleClik here to view.
New Drug Combination Treats Hepatitis C Patients Also Infected with HIV
Novel treatment has 97 percent success rate in co-infected patients — Roughly 20 to 30 percent of patients with hepatitis C virus (HCV) are also infected with human immunodeficiency virus type 1 (HIV)....
View ArticleClik here to view.
UC San Diego Launches New Nonalcoholic Fatty Liver Disease Research Center
Roughly one-quarter of all Americans – an estimated 100 million adults and children – have nonalcoholic fatty liver disease (NAFLD), a chronic condition that can lead to cirrhosis, liver cancer and...
View ArticleClik here to view.
Dr. Bernd Schnabl and Coworkers Find Another Way Alcohol Damages the Liver
Natural gut antibiotics diminished by alcohol leave mice more prone to bacterial growth in the liver, exacerbating alcohol-induced liver disease — Alcohol itself can directly damage liver cells. Now...
View ArticleClik here to view.
Fatty Liver Disease and Scarring Have Strong Genetic Component
Researchers at the University of California, San Diego School of Medicine say that hepatic fibrosis, which involves scarring of the liver that can result in dysfunction and, in severe cases, cirrhosis...
View ArticleClik here to view.
Novel 3D Imaging Offers New Tool for Identifying Advanced Fibrosis in Liver
UC San Diego School of Medicine NAFLD Research Center finds MRE imaging provides highly accurate, less invasive method — Nonalcoholic fatty liver disease, or NAFLD, comprises a group of liver disorders...
View Article
